Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|November 17, 2007
The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccineGeorge Hui, Caryn Hashimoto
Vaccine|October 7, 2006
Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopesGeorge Hui, Caryn Hashimoto
Vaccine|August 11, 2007
Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccineGeorge Hui, Caryn Hashimoto
Clinical and Vaccine Immunology : CVI|June 20, 2008
Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockoutsGeorge Hui, Dan Choe, Caryn Hashimoto
Experimental Parasitology|November 23, 2006
Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodiesMark Nagata, Teri Wong, David Clements, et al.
Plos One|October 8, 2013
Antibody and T cell responses in reciprocal prime-boost studies with full-length and truncated merozoite surface protein 1-42 vaccinesKae Pusic, Danielle Clements, Sophie Kobuch, et al.
Vaccine|October 4, 2011
Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodiesKae Pusic, Hengyi Xu, Andrew Stridiron, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 2012
Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccineKae Pusic, Zoraida Aguilar, Jaclyn McLoughlin, et al.
Vaccine|September 5, 2006
Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine developmentDon Yuen, Wai-Hang Leung, Randy Cheung, et al.
Ethnicity & Disease|January 24, 2020
The NIDDK High School Short-Term Research Experience for Underrepresented PersonsRobert Rivers, Keith C Norris, George Hui, et al.
Pageof 1